![Giorgio Fassina](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profiel
Giorgio Fassina is the founder and current Chairman of Xeptagen SpA, which is founded in 2001.
He is also currently a Professor at Alma Mater Studiorum - Università di Bologna, where he has been working since 1995.
Dr. Fassina received a doctorate degree from the University of Padua.
Actieve functies van Giorgio Fassina
| Bedrijven | Functie | Begin |
|---|---|---|
Xeptagen SpA
 Xeptagen SpA Medical SpecialtiesHealth Technology Engages in the discovery and validation of molecular biomarkers in order to produce diagnostic kits for cancer early detection, monitoring, and evaluation of response to therapy | Oprichter | 01-01-2001 |
Alma Mater Studiorum - Università di Bologna
 Alma Mater Studiorum - Università di Bologna Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01-01-1995 |
Opleiding van Giorgio Fassina
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
86
Eerstegraads connecties
3
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 3 |
|---|---|
University of Padua
 University of Padua Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alma Mater Studiorum - Università di Bologna
Alma Mater Studiorum - Università di Bologna Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Xeptagen SpA
Xeptagen SpA Medical SpecialtiesHealth Technology Engages in the discovery and validation of molecular biomarkers in order to produce diagnostic kits for cancer early detection, monitoring, and evaluation of response to therapy | Health Technology |
